The search is on for the next Director and Chief Executive Officer of The Pirbright Institute. 

The successful candidate will be an internationally recognised scientist and strategic leader capable of guiding the organisation through its next phase of scientific innovation and growth following the retirement of Professor Bryan Charleston MRCVS FRS.

Reporting to the Board of Trustee Directors, the new Director and CEO will provide overall scientific, strategic and organisational leadership, ensuring Pirbright remains at the forefront of international research and innovation while delivering its unique responsibilities as a national capability from its internationally acclaimed high containment site at Pirbright near Woking.

Pirbright seeks a leader with an internationally distinguished scientific reputation and significant experience of leading complex, research-intensive organisations. The successful candidate will be expected to strengthen Pirbright's global standing, secure sustainable funding, build strategic partnerships and inspire a high-performing and inclusive culture.

Helen Watts, interim CEO, said: 

“The appointment comes at an important time for the Institute as we head towards our next funding cycle. We have continued to invest in world-class facilities and expertise to prevent and control viral diseases that threaten livestock, food security and public health. 

"Our future leader will have the legacy of BBSRC-UKRI investment in Pirbright at their disposal, including the BBSRC’s national vaccinology and virology centres, plus the exciting prospect of working within the new Centre for Veterinary Vaccination Innovation and Manufacturing (CVIM), which will focus on vaccine development for Low-to-Middle Income countries.” 

Pirbright's mission is to be the world's leading innovative centre for preventing and controlling viral diseases of livestock, supporting both UK and global efforts to combat emerging disease threats. 

For more information about the permanent Director and CEO role, click here. Applications are open until 21st December.

For further details about the Pirbright Institute, follow us on LinkedIn or visit our website.